HORMONE-RESISTANT PROSTATE CANCER
Clinical trials for HORMONE-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HORMONE-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat prostate cancer: adding immunotherapy to current drug
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab can help men whose advanced prostate cancer has stopped responding to the standard drug enzalutamide. About 58 men with castration-resistant prostate cancer that has spread will receive pembrolizumab while conti…
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Diet before chemo may cut side effects in breast and prostate cancer
Symptom relief OngoingThis study tests whether eating a low-calorie diet before chemotherapy can reduce side effects like fatigue, nausea, and mouth sores, and also improve how well the treatment works. About 130 people with breast or prostate cancer will be randomly assigned to either follow the diet…
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Scientists hunt for genetic clues in advanced prostate cancer
Knowledge-focused OngoingThis study looks at genes in men with advanced prostate cancer that has spread and is no longer responding to hormone therapy. Researchers will analyze tissue, blood, and urine samples from 92 patients receiving a drug called abiraterone. The goal is to find genetic changes that …
Matched conditions: HORMONE-RESISTANT PROSTATE CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC